These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 17217945
1. Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors. Wise LE, Shelton CC, Cravatt BF, Martin BR, Lichtman AH. Eur J Pharmacol; 2007 Feb 14; 557(1):44-8. PubMed ID: 17217945 [Abstract] [Full Text] [Related]
2. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase. Haller VL, Stevens DL, Welch SP. Eur J Pharmacol; 2008 Dec 14; 600(1-3):50-8. PubMed ID: 18762181 [Abstract] [Full Text] [Related]
3. Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice. Wiley JL, Razdan RK, Martin BR. Life Sci; 2006 Dec 03; 80(1):24-35. PubMed ID: 16978656 [Abstract] [Full Text] [Related]
4. In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569. Gamage TF, Ignatowska-Jankowska BM, Wiley JL, Abdelrahman M, Trembleau L, Greig IR, Thakur GA, Tichkule R, Poklis J, Ross RA, Pertwee RG, Lichtman AH. Behav Pharmacol; 2014 Apr 03; 25(2):182-5. PubMed ID: 24603340 [Abstract] [Full Text] [Related]
5. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors. Desroches J, Charron S, Bouchard JF, Beaulieu P. Neuropharmacology; 2014 Feb 03; 77():441-52. PubMed ID: 24148808 [Abstract] [Full Text] [Related]
10. Anandamide effects on 5-HT(3) receptors in vivo. Rácz I, Bilkei-Gorzo A, Markert A, Stamer F, Göthert M, Zimmer A. Eur J Pharmacol; 2008 Oct 31; 596(1-3):98-101. PubMed ID: 18775693 [Abstract] [Full Text] [Related]
11. Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. Lichtman AH, Hawkins EG, Griffin G, Cravatt BF. J Pharmacol Exp Ther; 2002 Jul 31; 302(1):73-9. PubMed ID: 12065702 [Abstract] [Full Text] [Related]
16. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Moreira FA, Kaiser N, Monory K, Lutz B. Neuropharmacology; 2008 Jan 17; 54(1):141-50. PubMed ID: 17709120 [Abstract] [Full Text] [Related]
18. Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation. Habayeb OM, Taylor AH, Bell SC, Taylor DJ, Konje JC. Endocrinology; 2008 Oct 17; 149(10):5052-60. PubMed ID: 18599552 [Abstract] [Full Text] [Related]